TWD 70.7
(-3.42%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 100.83 Million TWD | 0.0% |
2022 | - TWD | 0.0% |
2021 | - TWD | 0.0% |
2020 | - TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 88.96 Million TWD | -11.77% |
2024 Q2 | 89.43 Million TWD | 0.54% |
2023 Q2 | 375.68 Million TWD | 0.0% |
2023 FY | 100.83 Million TWD | 0.0% |
2023 Q1 | - TWD | 0.0% |
2023 Q4 | 100.83 Million TWD | -37.92% |
2023 Q3 | 162.42 Million TWD | -56.77% |
2022 Q4 | - TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Allied Biotech Corporation | 72.02 Million TWD | -39.996% |
GeneFerm Biotechnology Co., Ltd. | 76.14 Million TWD | -32.413% |
Easywell Biomedicals, Inc. | 330.44 Million TWD | 69.487% |
TTY Biopharm Company Limited | 403.04 Million TWD | 74.983% |
Synmosa Biopharma Corporation | 1.45 Billion TWD | 93.088% |
Orient EuroPharma Co., Ltd. | 2.2 Billion TWD | 95.423% |
Center Laboratories, Inc. | 4.42 Billion TWD | 97.723% |
Tien Liang BioTech Co., Ltd. | 377 Thousand TWD | -26645.623% |
Orient Pharma Co., Ltd. | 323.73 Million TWD | 68.854% |
InnoPharmax Inc. | 5.38 Million TWD | -1772.094% |
Excelsior Biopharma Inc. | 300.25 Million TWD | 66.418% |
DV Biomed Co., Ltd. | 315.74 Million TWD | 68.066% |
Foresee Pharmaceuticals Co., Ltd. | 13.11 Million TWD | -668.822% |
Handa Pharmaceuticals, Inc. | 7.67 Million TWD | -1214.444% |
UniPharma Co., Ltd. | - TWD | -Infinity% |
Anxo Pharmaceutical Co., Ltd. | 499.69 Million TWD | 79.821% |
Alar Pharmaceuticals Inc. | 138 Thousand TWD | -72965.942% |
Winston Medical Supply Co., Ltd. | 56.05 Million TWD | -79.872% |
Mercury Biopharmaceutical Corporation | 41.66 Million TWD | -141.987% |
Bioray Biotech Co., Ltd | 65.65 Million TWD | -53.577% |
TSH Biopharm Corporation Limited | - TWD | -Infinity% |